BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morlet, N.
Right arrow Articles by the Ofloxacin Study Group,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morlet, N.
Right arrow Articles by the Ofloxacin Study Group,
Br J Ophthalmol 1999;83:1027-1031 ( September )

Risk factors for treatment outcome of suspected microbial keratitis

Nigel Morlet, Darwin Minassian, Jeremy Butcher, the Ofloxacin Study Group*

Correspondence to: J K G Dart, Moorfields Eye Hospital, City Road, London EC1V 2PD.

Accepted for publication 4 May 1999

BACKGROUND---Primary treatment for suspected microbial keratitis is generally successful. Although risks such as contact lens use are well recognised as causative factors for microbial keratitis, little is known about the risk factors that influence treatment outcome. The present study evaluates the risk factors assessed at diagnosis as prognostic indicators of primary treatment failure.
METHODS---Patients were prospectively enrolled in the ofloxacin treatment trial and data concerning symptoms, treatments, past and concurrent eye disease were collected along with the measurement of corneal ulcer size at the slit lamp. All patients were scraped for microbiological investigation, and treated with either ofloxacin (0.3%) or standard therapy of fortified cefuroxime and gentamicin drops. Treatment success was complete healing of the ulcer with zero dimensions of the epithelial defect within 2 weeks of start of treatment. The important prognostic indicators were selected by comparison among those who failed treatment, had delayed healing, or were culture positive with other patients using univariate and stratified analysis. These were then used in a Poisson model for multiple regression analysis to estimate the relative risk of the main prognostic variables.
RESULTS---Of the 118 patients enrolled in the study, 14 were identified as primary treatment failures, 17 had slow healing, and 15 indolent ulcers. There were 49 culture positive patients. The multivariate analysis identified that large culture positive ulcers in patients 60 years or older had 5.5 times the risk of primary treatment failure (p<0.001). Significant predictors of slow healing were previous ocular disease and a positive culture; significant predictors of indolent ulceration were previous ocular disease and steroid use at diagnosis; the main predictor of a culture positive result was ulcer size.
CONCLUSIONS---Elderly patients with large ulcers were more likely to be culture positive, fail primary therapy, and require surgical intervention. A positive microbial culture provided prognostic information regardless of the organism isolated. However, this information was of less value for those with small ulcers and for younger patients.


* Members listed at the end of the paper.


© 1999 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
F. Al-Shakarchi
Initial therapy for suppurative microbial keratitis in Iraq
Br. J. Ophthalmol., December 1, 2007; 91(12): 1583 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T K H Butler, N A Spencer, C C K Chan, J S. Gilhotra, and K McClellan
Infective keratitis in older patients: a 4 year review, 1998-2002
Br. J. Ophthalmol., May 1, 2005; 89(5): 591 - 596.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M I Bosscha, J T van Dissel, E J Kuijper, W Swart, and M J Jager
The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulceration
Br. J. Ophthalmol., January 1, 2004; 88(1): 25 - 28.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
K. R. Wilhelmus, R. L. Abshire, and B. A. Schlech
Influence of Fluoroquinolone Susceptibility on the Therapeutic Response of Fluoroquinolone-Treated Bacterial Keratitis
Arch Ophthalmol, September 1, 2003; 121(9): 1229 - 1233.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T Wong, S Ormonde, G Gamble, and C N J McGhee
Severe infective keratitis leading to hospital admission in New Zealand
Br. J. Ophthalmol., September 1, 2003; 87(9): 1103 - 1108.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
N Morlet and M Daniell
View 2: Empirical fluoroquinolone therapy is sufficient initial treatment
Br. J. Ophthalmol., September 1, 2003; 87(9): 1169 - 1172.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. B. Kaye, P. G. Rao, G. Smith, J. A. Scott, S. Hoyles, C. E. Morton, C. Willoughby, M. Batterbury, and G. Harvey
Simplifying Collection of Corneal Specimens in Cases of Suspected Bacterial Keratitis
J. Clin. Microbiol., July 1, 2003; 41(7): 3192 - 3197.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T Bourcier, F Thomas, V Borderie, C Chaumeil, and L Laroche
Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases
Br. J. Ophthalmol., July 1, 2003; 87(7): 834 - 838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.